Dr B Baragana

I graduated in Organic Chemistry and then completed my studies with a PhD under the supervision of Professor Jose Barluenga at Universidad de Oviedo in 1998. After my PhD, I worked first as Research Fellow at Trinity College Dublin in Prof. A. P. Davis’ group for a year and then as postdoctoral medicinal chemist at the Medicinal Chemistry Department at Bayer AG in Wuppertal, Germany. I moved to Scotland in 2001. In Scotland I gained further industrial experience working for five years in Avecia as R&D Chemist and then as Team Leader. In 2007, I joined the University of Dundee where I lead the malaria project team of the Drug Discovery Unit. The DDU malaria team developed an exciting antimalarial compound that has been selected as a preclinical candidate by the non-for profit organisation, Medicines for Malaria Venture, and subsequently partnered with the pharmaceutical company Merck Serono.
For more information, see:

A novel multiple-stage antimalarial agent that inhibits protein synthesis, Beatriz Baragaña et al. Nature 522, 315–320, 2015.


Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy; Beatriz Baragaña et al. J. Med. Chem., 2016